Suppr超能文献

生长激素受体下调的决定因素。

Determinants of growth hormone receptor down-regulation.

作者信息

Deng Luqin, He Kai, Wang Xiangdong, Yang Ning, Thangavel Chellappagounder, Jiang Jing, Fuchs Serge Y, Frank Stuart J

机构信息

Department of Cell Biology, Division of Endocrinology, Diabetes, and Metabolism, University of Alabama at Birmingham, Birmingham, Alabama 35294-0012, USA.

出版信息

Mol Endocrinol. 2007 Jul;21(7):1537-51. doi: 10.1210/me.2007-0138. Epub 2007 May 8.

Abstract

GH receptor (GHR) is a cytokine receptor family member that responds to GH by activation of the receptor-associated tyrosine kinase, JAK2 (Janus family of tyrosine kinase 2). We previously showed that JAK2, in addition to being a signal transducer, dramatically increases the half-life of mature GHR, partly by preventing constitutive GHR down-regulation. Herein we explored GHR and JAK2 determinants for both constitutive and GH-induced GHR down-regulation, exploiting the previously characterized GHR- and JAK2-deficient gamma2A reconstitution system. We found that JAK2's ability to protect mature GHR from rapid degradation measured in the presence of the protein synthesis inhibitor, cycloheximide, depended on the presence of GHR's Box 1 element and the intact JAK2 FERM (band 4.1/Ezrin/Radixin/Moesin); domain, but not the kinase-like or kinase domains of JAK2. Thus, GHR-JAK2 association, but not JAK2 kinase activity, is required for JAK2 to inhibit constitutive GHR down-regulation and enhance GHR half-life. In cells that expressed JAK2, but not cells lacking JAK2, GH markedly enhanced GHR degradation. Like JAK2-induced protection from constitutive down-regulation, GH-induced GHR down-regulation required the GHR Box 1 element and an intact JAK2 FERM domain. However, a JAK2 mutant lacking the kinase-like and kinase domains did not mediate GH-induced GHR down-regulation. Likewise, a kinase-deficient JAK2 was insufficient for this purpose, indicating that kinase activity is required. Both lactacystin (a proteasome inhibitor) and chloroquine (a lysosome inhibitor) blocked GH-induced GHR loss. Interestingly, GH-induced GHR ubiquitination, like down-regulation, was prevented in cells expressing a kinase-deficient JAK2 protein. Further, a GHR mutant, of which all the cytoplasmic tyrosine residues were changed to phenylalanines, was resistant to GH-induced GHR ubiquitination and down-regulation. Collectively, our data suggest that determinants required for JAK2 to protect mature GHR from constitutive degradation differ from those that drive GH-induced GHR down-regulation. The latter requires GH-induced JAK2 activation and GHR tyrosine phosphorylation and is correlated to GHR ubiquitination in our reconstitution system.

摘要

生长激素受体(GHR)是细胞因子受体家族成员,通过激活受体相关酪氨酸激酶JAK2(酪氨酸激酶2的Janus家族)对生长激素作出反应。我们之前表明,JAK2除了作为信号转导子外,还能显著增加成熟GHR的半衰期,部分原因是防止组成型GHR下调。在此,我们利用先前表征的GHR和JAK2缺陷的γ2A重构系统,探索了组成型和生长激素诱导的GHR下调的GHR和JAK2决定因素。我们发现,在存在蛋白质合成抑制剂环己酰亚胺的情况下,JAK2保护成熟GHR免于快速降解的能力取决于GHR的Box 1元件和完整的JAK2 FERM(带4.1/埃兹蛋白/根蛋白/膜突蛋白)结构域,但不取决于JAK2的激酶样或激酶结构域。因此,JAK2抑制组成型GHR下调并延长GHR半衰期需要GHR-JAK2结合,但不需要JAK2激酶活性。在表达JAK2的细胞中,而不是在缺乏JAK2的细胞中,生长激素显著增强GHR降解。与JAK2诱导的免受组成型下调的保护作用一样,生长激素诱导的GHR下调需要GHR Box 1元件和完整的JAK2 FERM结构域。然而,缺乏激酶样和激酶结构域的JAK2突变体不能介导生长激素诱导的GHR下调。同样,激酶缺陷型JAK2也不足以达到此目的,表明需要激酶活性。乳胞素(一种蛋白酶体抑制剂)和氯喹(一种溶酶体抑制剂)都能阻断生长激素诱导的GHR丢失。有趣的是,在表达激酶缺陷型JAK2蛋白的细胞中,生长激素诱导的GHR泛素化与下调一样被阻止。此外,一种所有细胞质酪氨酸残基都被改变为苯丙氨酸的GHR突变体对生长激素诱导的GHR泛素化和下调具有抗性。总体而言,我们的数据表明,JAK2保护成熟GHR免于组成型降解所需的决定因素与驱动生长激素诱导的GHR下调的决定因素不同。后者需要生长激素诱导的JAK2激活和GHR酪氨酸磷酸化,并且在我们的重构系统中与GHR泛素化相关。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验